Categories: Business

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India

BusinessWire India

Hyderabad (Telangana) [India], September 19: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs.

The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies.

Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said: “This investment strengthens our ability to meet the growing global demand for high-quality veterinary pharmaceuticals while ensuring the highest standards of innovation, efficiency, and sustainability. We are proud to support our innovator partners in their mission of offering reliable solutions that enhance animal well-being.”

The market for veterinary APIs presents a significant growth opportunity, driven by increasing demand for veterinary medicines and advancements in animal healthcare. Sai Life Sciences’ investment in this facility aligns with its strategic vision to enhance its offerings in niche, high-value segments of the pharmaceutical industry. With over two decades of manufacturing expertise, Sai Life Sciences has established itself as a trusted partner in API production, known for its advanced process capabilities, operational excellence, and stringent quality standards. The new facility leverages advanced technologies, robust supply chain management, and best-in-class safety practices to ensure reliable and cost-effective manufacturing of animal health APIs.

(ADVERTORIAL DISCLAIMER: The above press release has been provided by BusinessWire India. ANI will not be responsible in any way for the content of the same)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews syndication

Recent Posts

Buriram United blow past Shanghai Port

VIDEO SHOWS: HIGHLIGHTS OF BURIRAM UNITED BEATING SHANGHAI PORT 2-0 IN THE AFC CHAMPIONS LEAGUE…

47 minutes ago

BRIEF-Strategy Enters Into An Omnibus Sales Agreement

Nov 4 (Reuters) - Strategy Inc: * STRATEGY: MAY OFFER, SELL SHARES OF VARIABLE RATE…

3 hours ago

IHeartMedia shares hit 2-year high on report of Netflix licensing talks

(Reuters) -Shares of iHeartMedia hit their highest in more than two years on Tuesday after…

4 hours ago

'Unexpected' cancer treatment discovery touted by scientists

Los Angeles (dpa) - Researchers at the Mayo Clinic in the United States say they…

4 hours ago

Uber operating profit hit by legal expenses, shares fall

By Akash Sriram (Reuters) -Uber missed operating profit expectations on Tuesday and issued a downbeat…

4 hours ago

UK's Starling signs software deal with Canada's Tangerine, plans 100 hires

By Lawrence White LONDON (Reuters) -Starling Group has signed a 10-year agreement to upgrade core…

5 hours ago